Has the cannabis craze now change into tulip mania 2.0?
Raymond James’ Dave Novak on whether or no longer the pot replace is all smoke and mirrors? With CNBC’s Melissa Lee and the Speedily Money traders, Tim Seymour, Brian Kelly,…
Tilray CEO on the first US marijuana IPO
Tilray CEO Brendan Kennedy discusses the clinical cannabis producer’s intial public providing as effectively as his outlook for the criminal marijuana industry.
Marijuana’s midterm 2nd
CNBC’s Aditi Roy reports on marijuana making ballots this midterm election in Missouri, Michigan, North Dakota and Utah. » Subscribe to CNBC: About CNBC: From ‘Wall Boulevard’ to ‘Foremost Boulevard’…
Pot stocks too expensive, says ‘dean of valuation’
Aswath Damodaran, NYU Stern Faculty of Industry, on the affect of the Canadian marijuana legalization match. With CNBC’s Aditi Roy and Melissa Lee, and the Immediate Cash traders, Tim Seymour,…
Tilray CEO Brendan Kennedy on hashish industry
CNBC’s “Energy Lunch” crew talks with Tilray CEO Brendan Kennedy about the expansion of the firm, the acquisition of Manitoba, and where the marketplace for hemp and CBD is headed….
There is a sizzling contemporary ETF that will perhaps enable you to play the cannabis dwelling
CNBC’s Bob Pisani breaks down YOLO, a 2nd marijuana-themed ETF that ultimate hit the market. Dave Nadig of ETF.com and Cantor Fitzgerald’s Reggie Brown weigh in.
Tilray CEO Irwin Simon: We’re correctly positioned no subject full U.S. legality of cannabis
Tilray CEO Irwin Simon joins ‘Dispute on the Avenue’ to discuss the firm’s quarterly earnings outcomes, whether or not investors perceive the firm’s growth yarn, and where the firm is…
Curaleaf Government Chairman: I feel we’re gonna accumulate a lag bipartisan vote from the Senate
Boris Jordan, Curaleaf govt chairman, joins ‘Immediate Money’ to discuss day after nowadays’s vote on the senate banking committee concerning cannabis companies banking privileges. For accumulate entry to to are…
Cronos deal presents Altria a world cannabis platform, says analyst
CNBC’s “Vitality Lunch” workforce discusses Altria’s investment in cannabis firm Cronos with Christopher Growe, an analyst at Stifel.
Present stays severe factors for cannabis companies, says analyst
Vivien Azer, Cowen senior analyst and managing director, discusses her views on the cannabis sector sooner than Canada’s legalization.